NIH-funded research Fellowship grant

Investigating how certain enzymes can help reduce physical decline in aging individuals

Official title: Targeting muscle kynurenine aminotransferases and the AHR pathway to mitigate age-related physical decline

Funded at University of Florida · NIH-10902589 · Data updated 2026-11-12

This study is looking at how certain enzymes might affect muscle strength and overall health as we age, especially in older adults, to find ways to help them stay strong and active.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startAugust 23, 2024
Project endMarch 3, 2026
Funding year2024
Award (this year)$79,756
NIH project number1F32AG087637-01
Project IDNIH-10902589 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults experiencing muscle weakness or frailty.

Less likely to help

Patients who are not elderly or do not exhibit signs of muscle weakness or frailty may not benefit from this research.

What this research studies

This research focuses on understanding the role of specific enzymes in the aging process, particularly how they relate to muscle weakness and frailty in older adults. By examining the relationship between elevated levels of L-kynurenine and age-related physical decline, the study aims to identify potential interventions that could reverse these effects. The approach involves analyzing the function of kynurenine aminotransferases and their impact on muscle health, with the goal of developing strategies to improve physical function in the elderly.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance physical function and quality of life for older adults.

How similar studies have gone: While there is emerging evidence linking kynurenine levels to frailty, this specific approach to targeting muscle enzymes in aging is relatively novel and has not been extensively tested.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Wimberly, Keon — University of Florida
  • Study coordinator: Wimberly, Keon

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.